***VACCINE REVIEW*** Here is our analysis of #OxfordAstraZeneca’s interim report of their #COVID19 vaccine (#ChAdOx1/#AZD1222). #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidVaccine

Our PICO, appraisal, and limitations for this trial looking at #tocilizumab vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #sarilumab vs. placebo for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

You can catch the review we did at CDEI.ca, and here is our infographic for the #OxfordAstraZeneca #COVID19 vaccine! #COVIDRx #COVID19Vacines #TwitterRx #MedTwitter

Our PICO, appraisal, and limitations for this trial looking at #methylprednisolone vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

*VACCINE REVIEW* Our outline, appraisal, and limitations for #Gamaleya’s interim report of their #COVID19 vaccine #Sputnik. Subscribe for future COVID-19 vaccine/treatment RCT updates at CDEI.ca! #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #Gamaleya

Our PICO, appraisal, and limitations for this trial looking at #azithromycin plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #anakinra with usual care vs. usual care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #ivermectin vs. placebo for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #tocilizumab plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #proxalutamide plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #methylprednisolone vs. placebo for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

A special thank you to our reviewers and co-founders for their many hours of work over the past (almost) year!

Our PICO, appraisal, and limitations for this trial looking at a variation of the following: #lopinavir, #ritonavir, #azithromycin, #doxycycline, #hydroxychloroquine vs. standard of care (single dose azithromycin) for #COVID19 #RCT #TwitteRx #clinicatrial #evidencebasedmedicine

Our PICO, appraisal, and limitations for this trial looking at #progesterone plus standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Our PICO, appraisal, & limitations for this trial looking at #tocilizumab + standard of care vs. standard of care for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

Our PICO, appraisal, and limitations for this trial looking at #vitamind3 in peanut oil vs. peanut oil solution for #COVID19 treatment. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx

Our PICO, appraisal, & limitations for this trial looking at a variation of #AscorbicAcid & #ZincGluconate vs. standard of care for #COVID19 Tx. #RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #evidencebasedmedicine #CovidRx

Thank you @GeriMedRisk - it was a great presentation by Sandra and Karen!

The CDEI team would like to announce that we will no longer be reviewing new RCTs for COVID-19 drugs/vaccines. At this time we plan to keep the trial archive on our website at cdei.ca. A big thank you to our reviewing team, our expert advisors & you, our followers